[Tacrolimus ointment in the management of atopic keratoconjunctivitis].
Sign Up to like & getrecommendations! Published in 2019 at "Journal francais d'ophtalmologie"
DOI: 10.1016/j.jfo.2018.07.018
Abstract: INTRODUCTION Atopic keratoconjunctivitis is associated with eyelid eczema. It may require the use of local corticosteroids which if prolonged can be a source of ocular complications. Tacrolimus is an immunosuppressant used in cutaneous application in… read more here.
Keywords: atopic; management atopic; tacrolimus ointment; atopic keratoconjunctivitis ... See more keywords
Dual Delivery of Fluticasone Propionate and Levocetirizine Dihydrochloride for the Management of Atopic Dermatitis Using a Microemulsion-Based Topical Gel
Sign Up to like & getrecommendations! Published in 2022 at "ACS Omega"
DOI: 10.1021/acsomega.1c06393
Abstract: The current study investigates the potential for topical delivery of a fluticasone propionate (FP) and levocetirizine dihydrochloride (CTZ)-loaded microemulsion (ME) for the management of atopic dermatitis. Various microemulsion components were chosen based on their solubility… read more here.
Keywords: atopic dermatitis; levocetirizine; microemulsion; management atopic ... See more keywords
Guidelines for the Management of Atopic Dermatitis in Children: A Systematic Review
Sign Up to like & getrecommendations! Published in 2022 at "International Archives of Allergy and Immunology"
DOI: 10.1159/000527007
Abstract: Introduction: Numerous guidelines have been published for atopic dermatitis management in children in recent years. To date, the quality of the newest guidelines has not been appraised. This study aimed to identify and evaluate guidelines… read more here.
Keywords: atopic dermatitis; atopic; dermatitis children; management atopic ... See more keywords
Management of Atopic Dermatitis: Clinical Utility of Ruxolitinib
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s342051
Abstract: Abstract Atopic dermatitis (AD) is a common chronic, pruritic inflammatory skin disease that profoundly impacts patients’ quality of life. As the first FDA-approved topical JAK inhibitor, ruxolitinib 1.5% cream represents a novel therapeutic topical agent… read more here.
Keywords: ruxolitinib; atopic dermatitis; ruxolitinib cream; management atopic ... See more keywords
Pathophysiology and Management of Atopic Dermatitis: A Laconic Review
Sign Up to like & getrecommendations! Published in 2020 at "Current Drug Therapy"
DOI: 10.2174/1574885514666190828152316
Abstract: Atopic Dermatitis (AD) is long-lasting degenerating skin disease with a characteristic phenotype and stereotypically spread skin lesions. The AD results due to a complex interface among genetic factors, host’s surroundings, pharmacological anomalies and immunological factors.… read more here.
Keywords: dermatitis laconic; laconic review; management; atopic dermatitis ... See more keywords
Recent Trends in Nanocarriers for the Management of Atopic Dermatitis.
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceutical nanotechnology"
DOI: 10.2174/2211738511666230330115229
Abstract: BACKGROUND Atopic dermatitis (AD) is a pruritic inflammatory skin condition with increasing global prevalence, almost affecting 15% to 30% of children and 5% of adults. AD results due to a complex interaction between the impaired… read more here.
Keywords: atopic dermatitis; recent trends; management; management atopic ... See more keywords